Annual Long Term Debt
$0.00
-$64.00 K-100.00%
31 December 2023
Summary:
GT Biopharma annual long term debt is currently $0.00, with the most recent change of -$64.00 thousand (-100.00%) on 31 December 2023. GTBP annual long term debt is now -100.00% below its all-time high of $1.61 million, reached on 31 December 1998.GTBP Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
N/A
30 September 2024
Summary:
GT Biopharma quarterly long term debt is not available.GTBP Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
GTBP Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | |||
| 5 y | 5 years | -100.0% | |||
| alltime | all time | -100.0% |
GT Biopharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $31.00 K(-51.6%) |
| Dec 2022 | $64.00 K(>+9900.0%) | $64.00 K(-30.4%) |
| Sept 2022 | - | $92.00 K(-23.3%) |
| June 2022 | - | $120.00 K(-18.4%) |
| Mar 2022 | - | $147.00 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $400.00 K(-24.2%) |
| June 2016 | - | $528.00 K(-4.5%) |
| Mar 2016 | - | $553.00 K(-22.5%) |
| Dec 2015 | $714.00 K(+12.6%) | $714.00 K(-68.8%) |
| Sept 2015 | - | $2.29 M(+57.8%) |
| June 2015 | - | $1.45 M(+70.9%) |
| Mar 2015 | - | $849.00 K(+33.9%) |
| Dec 2014 | $634.00 K(+553.6%) | $634.00 K(+107.2%) |
| Sept 2014 | - | $306.00 K(+96.2%) |
| June 2014 | - | $156.00 K(+21.9%) |
| Mar 2014 | - | $128.00 K(+32.0%) |
| Dec 2013 | $97.00 K(-61.0%) | $97.00 K(-76.0%) |
| Sept 2010 | - | $404.00 K(0.0%) |
| June 2010 | - | $404.00 K(-18.5%) |
| Mar 2010 | - | $496.00 K(+99.2%) |
| Dec 2009 | $249.00 K | $249.00 K(-60.4%) |
| Sept 2007 | - | $628.00 K(+37.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | $458.00 K(+57.9%) |
| Mar 2007 | - | $290.00 K(+133.9%) |
| Dec 2006 | $124.00 K(+6100.0%) | $124.00 K(+6100.0%) |
| Dec 2001 | $2000.00(-98.7%) | $2000.00(-98.7%) |
| June 2001 | - | $156.00 K(+9.1%) |
| Mar 2001 | - | $143.00 K(-4.7%) |
| Dec 2000 | $150.00 K(-22.7%) | $150.00 K(-6.3%) |
| Sept 2000 | - | $160.00 K(-4.8%) |
| June 2000 | - | $168.00 K(-10.6%) |
| Mar 2000 | - | $188.00 K(-3.1%) |
| Dec 1999 | $194.00 K(-88.0%) | $194.00 K(-3.0%) |
| Sept 1999 | - | $200.00 K(0.0%) |
| June 1999 | - | $200.00 K(0.0%) |
| Mar 1999 | - | $200.00 K(-87.6%) |
| Dec 1998 | $1.61 M(+0.8%) | $1.61 M(+0.8%) |
| Sept 1998 | - | $1.60 M(-5.9%) |
| June 1998 | - | $1.70 M(0.0%) |
| Mar 1998 | - | $1.70 M(+6.3%) |
| Dec 1997 | $1.60 M(+23.1%) | $1.60 M(+23.1%) |
| Mar 1996 | - | $1.30 M(0.0%) |
| Dec 1995 | $1.30 M(+333.3%) | $1.30 M(+225.0%) |
| Sept 1995 | - | $400.00 K(-20.0%) |
| June 1995 | - | $500.00 K(+66.7%) |
| Mar 1995 | - | $300.00 K(0.0%) |
| Dec 1994 | $300.00 K | $300.00 K(-40.0%) |
| Sept 1994 | - | $500.00 K |
FAQ
- What is GT Biopharma annual long term debt?
- What is the all time high annual long term debt for GT Biopharma?
- What is GT Biopharma annual long term debt year-on-year change?
- What is the all time high quarterly long term debt for GT Biopharma?
What is GT Biopharma annual long term debt?
The current annual long term debt of GTBP is $0.00
What is the all time high annual long term debt for GT Biopharma?
GT Biopharma all-time high annual long term debt is $1.61 M
What is GT Biopharma annual long term debt year-on-year change?
Over the past year, GTBP annual long term debt has changed by -$64.00 K (-100.00%)
What is the all time high quarterly long term debt for GT Biopharma?
GT Biopharma all-time high quarterly long term debt is $2.29 M